GHP-88310 blocks airborne and contact transmission in ferret measles model

A new antiviral candidate, GHP-88310, shows strong promise for preventing measles-like disease transmission in a ferret model, according to a study published in Nature Microbiology. The work targets one of the key challenges in highly contagious respiratory viruses: stopping spread that occurs both through direct contact and via the air.

The researchers evaluated whether GHP-88310 could interfere with infection and contagiousness after exposure. Using ferrets—an established system for modeling aspects of human measles-like illness—the team assessed how treatment influenced the likelihood that animals would become infected following close interaction with diseased counterparts.

To probe airborne transmission, the investigators designed experiments in which healthy ferrets were separated from infected animals while still sharing an airflow environment. This approach allowed the study to distinguish between pathogens transmitted by physical contact and those capable of moving through the air.

Across both experimental routes, GHP-88310 substantially reduced transmission. The findings suggest the compound limits critical steps in the infectious process, potentially lowering the amount or effectiveness of virus produced during infection and thereby reducing the probability of successful spread.

The study also emphasizes timing and pharmacological action. Viral transmission is highly sensitive to how quickly a therapeutic can suppress replication after exposure. By focusing on an antiviral that can act during the window when infectious virus is being generated, the researchers aim to reduce the opportunity for onward infection.

Together, the results position GHP-88310 as a candidate for scenarios where rapid post-exposure intervention is necessary—such as outbreaks involving measles-like pathogens with high reproductive numbers. A key implication is that a single intervention strategy may help curb both direct and airborne routes rather than requiring separate countermeasures.

If these effects translate beyond the ferret model, antivirals like GHP-88310 could complement vaccination and public health controls by adding a targeted layer of defense during early stages of an outbreak, when transmission can surge before immunity fully takes hold.

The authors conclude that blocking contact-mediated and airborne spread in vivo provides a compelling rationale for further development, including optimization of dosing, assessment of durability of protection, and evaluation of safety across relevant exposure contexts.